益生菌膳食補充劑市場－全球產業規模、佔有率、趨勢、機會與預測，按形式、最終用途、應用、地區和競爭細分，2020-2030 年

2024 年全球益生菌膳食補充劑市場價值為 87.6 億美元，預計在預測期內實現強勁成長，到 2030 年年複合成長率(CAGR) 為 10.75%。

由於消費者行為明顯轉向科學驗證和積極主動的健康管理方法，市場正在經歷加速擴張。益生菌——經臨床證明對腸道和免疫健康有益的活性微生物菌株——正在成為廣泛消費者群體中循證營養策略的一個組成部分。

這種日益成長的採用與生活方式相關的健康狀況的日益流行密切相關，包括胃腸道疾病、免疫反應減弱和慢性發炎 - 特別是在成年人和老年人群中。消費者越來越傾向於天然、非藥物的替代品，從而刺激了對符合清潔標籤原則和預防性保健實踐的益生菌產品的需求。

關鍵市場促進因素

胃腸道疾病和生活方式相關疾病盛行率上升

主要市場挑戰

品質控制和產品標準化

主要市場趨勢

個人化營養的出現

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球益生菌膳食補充劑市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 按劑型（咀嚼片和軟糖、膠囊、粉末、片劑和軟膠囊、其他）
  • 依最終用途（嬰兒、兒童、成人、老年人）
  • 按應用（運動健身、能量與體重管理、一般健康、骨骼與關節健康、胃腸道健康、免疫力、心臟健康、糖尿病、抗癌、皮膚/頭髮/指甲、大腦/心理健康、其他）
  • 按地區
  • 按公司分類（2024）
• 產品市場圖

第6章：北美益生菌膳食補充劑市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲益生菌膳食補充劑市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙

第8章：亞太益生菌膳食補充劑市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國

第9章：南美洲益生菌膳食補充劑市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第 10 章：中東和非洲益生菌膳食補充劑市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 科威特

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 近期發展
• 併購
• 產品發布

第 13 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 顧客的力量
• 替代產品的威脅

第 14 章：競爭格局

• Vitakem Nutraceutical Inc
• Lesaffre International Corp
• DuPont de Nemours Inc
• H&H Group PLC
• Amway Corp
• Abbott Laboratories Inc
• Bayer AG
• Pfizer Inc.
• GSK PLC
• BASF SE

第 15 章：策略建議

第16章調查會社について,免責事項

The Global Probiotics Dietary Supplements Market was valued at USD 8.76 billion in 2024 and is projected to achieve strong growth over the forecast period, with a compound annual growth rate (CAGR) of 10.75% through 2030.

The market is experiencing accelerated expansion, driven by a clear shift in consumer behavior toward scientifically validated and proactive approaches to health management. Probiotics-live microbial strains with clinically proven benefits for gut and immune health-are becoming an integral component of evidence-based nutritional strategies across a broad range of consumer demographics.

This growing adoption is closely tied to the increasing prevalence of lifestyle-related health conditions, including gastrointestinal disorders, weakened immune response, and chronic inflammation-particularly among adults and aging populations. Consumers are gravitating toward natural, non-pharmaceutical alternatives, fueling demand for probiotic products that align with clean-label principles and preventive wellness practices.

Key Market Drivers

Rising Prevalence of Gastrointestinal and Lifestyle-Related Disorders

The surge in gastrointestinal (GI) and lifestyle-related disorders is a key growth driver for the probiotics dietary supplements market. Non-communicable diseases (NCDs), which include many of these disorders, have become the dominant global health challenge, accounting for approximately 75% of all non-pandemic-related deaths. In 2021, NCDs were responsible for over 43 million deaths worldwide, with cardiovascular conditions leading the count.

This shift has influenced both consumer behavior and healthcare priorities, positioning probiotics as an essential element of preventive and therapeutic strategies focused on gut health and overall well-being. Digestive issues such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), acid reflux, constipation, and bloating are increasingly common across various age groups and geographies, further driving demand for probiotic supplementation.

Key Market Challenges

Quality Control and Product Standardization

Maintaining the quality, efficacy, and stability of probiotic supplements remains a significant challenge. As live microorganisms, probiotics must remain viable throughout the entire production, packaging, storage, and distribution cycle. Any degradation in potency can result in inconsistent health outcomes and potentially undermine consumer confidence. Ensuring stringent quality standards and formulation integrity is therefore critical for sustained market growth and credibility.

Key Market Trends

Emergence of Personalized Nutrition

The growing demand for individualized health solutions is reshaping the probiotics landscape. Personalized nutrition-including custom probiotic formulations-is gaining momentum as consumers increasingly seek products tailored to their unique physiological needs. Innovations such as DNA testing and microbiome analysis are enabling the identification of specific probiotic strains that deliver targeted benefits based on individual health profiles, paving the way for highly personalized and effective wellness interventions.

Key Market Players

• Vitakem Nutraceutical Inc
• Lesaffre International Corp
• DuPont de Nemours Inc
• H&H Group PLC
• Amway Corp
• Abbott Laboratories Inc
• Bayer AG
• Pfizer Inc.
• GSK PLC
• BASF SE

Report Scope:

In this report, the Global Probiotics Dietary Supplements Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Probiotics Dietary Supplements Market, By Form:

• Chewables & Gummies
• Capsules
• Powders
• Tablets & Softgels
• Others

Probiotics Dietary Supplements Market, By End-Use:

• Infants
• Children
• Adults
• Geriatric

Probiotics Dietary Supplements Market, By Application:

• Sports Fitness
• Energy & Weight Management
• General Health
• Bone & Joint Health
• Gastrointestinal Health
• Immunity
• Cardiac Health
• Diabetes
• Anti-cancer
• Skin/Hair/Nails
• Brain/Mental Health
• Others

Probiotics Dietary Supplements Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Probiotics Dietary Supplements Market.

Available Customizations:

Global Probiotics Dietary Supplements market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Probiotics Dietary Supplements Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
  • 5.2.2. By End-use (Infants, Children, Adults, Geriatric)
  • 5.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Product Market Map

6. North America Probiotics Dietary Supplements Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
  • 6.2.2. By End-use (Infants, Children, Adults, Geriatric)
  • 6.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Probiotics Dietary Supplements Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Form
      • 6.3.1.2.2. By End-use
      • 6.3.1.2.3. By Applications
  • 6.3.2. Canada Probiotics Dietary Supplements Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Form
      • 6.3.2.2.2. By End-use
      • 6.3.2.2.3. By Applications
  • 6.3.3. Mexico Probiotics Dietary Supplements Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Form
      • 6.3.3.2.2. By End-use
      • 6.3.3.2.3. By Applications

7. Europe Probiotics Dietary Supplements Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
  • 7.2.2. By End-use (Infants, Children, Adults, Geriatric)
  • 7.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Probiotics Dietary Supplements Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Form
      • 7.3.1.2.2. By End-use
      • 7.3.1.2.3. By Applications
  • 7.3.2. United Kingdom Probiotics Dietary Supplements Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Form
      • 7.3.2.2.2. By End-use
      • 7.3.2.2.3. By Applications
  • 7.3.3. France Probiotics Dietary Supplements Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Form
      • 7.3.3.2.2. By End-use
      • 7.3.3.2.3. By Applications
  • 7.3.4. Italy Probiotics Dietary Supplements Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Form
      • 7.3.4.2.2. By End-use
      • 7.3.4.2.3. By Applications
  • 7.3.5. Spain Probiotics Dietary Supplements Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Form
      • 7.3.5.2.2. By End-use
      • 7.3.5.2.3. By Applications

8. Asia-Pacific Probiotics Dietary Supplements Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
  • 8.2.2. By End-use (Infants, Children, Adults, Geriatric)
  • 8.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Probiotics Dietary Supplements Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Form
      • 8.3.1.2.2. By End-use
      • 8.3.1.2.3. By Applications
  • 8.3.2. Japan Probiotics Dietary Supplements Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Form
      • 8.3.2.2.2. By End-use
      • 8.3.2.2.3. By Applications
  • 8.3.3. India Probiotics Dietary Supplements Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Form
      • 8.3.3.2.2. By End-use
      • 8.3.3.2.3. By Applications
  • 8.3.4. Australia Probiotics Dietary Supplements Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Form
      • 8.3.4.2.2. By End-use
      • 8.3.4.2.3. By Applications
  • 8.3.5. South Korea Probiotics Dietary Supplements Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Form
      • 8.3.5.2.2. By End-use
      • 8.3.5.2.3. By Applications

9. South America Probiotics Dietary Supplements Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
  • 9.2.2. By End-use (Infants, Children, Adults, Geriatric)
  • 9.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Probiotics Dietary Supplements Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Form
      • 9.3.1.2.2. By End-use
      • 9.3.1.2.3. By Applications
  • 9.3.2. Argentina Probiotics Dietary Supplements Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Form
      • 9.3.2.2.2. By End-use
      • 9.3.2.2.3. By Applications
  • 9.3.3. Colombia Probiotics Dietary Supplements Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Form
      • 9.3.3.2.2. By End-use
      • 9.3.3.2.3. By Applications

10. Middle East and Africa Probiotics Dietary Supplements Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
  • 10.2.2. By End-use (Infants, Children, Adults, Geriatric)
  • 10.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Probiotics Dietary Supplements Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Form
      • 10.3.1.2.2. By End-use
      • 10.3.1.2.3. By Applications
  • 10.3.2. Saudi Arabia Probiotics Dietary Supplements Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Form
      • 10.3.2.2.2. By End-use
      • 10.3.2.2.3. By Applications
  • 10.3.3. UAE Probiotics Dietary Supplements Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Form
      • 10.3.3.2.2. By End-use
      • 10.3.3.2.3. By Applications
  • 10.3.4. Kuwait Probiotics Dietary Supplements Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Form
      • 10.3.4.2.2. By End-use
      • 10.3.4.2.3. By Applications

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Vitakem Nutraceutical Inc
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Lesaffre International Corp
• 14.3. DuPont de Nemours Inc
• 14.4. H&H Group PLC
• 14.5. Amway Corp
• 14.6. Abbott Laboratories Inc
• 14.7. Bayer AG
• 14.8. Pfizer Inc.
• 14.9. GSK PLC
• 14.10. BASF SE

15. Strategic Recommendations

16. About Us & Disclaimer